TOMBOLINI, Vincenzo
 Distribuzione geografica
Continente #
NA - Nord America 12.911
EU - Europa 4.135
AS - Asia 2.197
SA - Sud America 83
AF - Africa 78
Continente sconosciuto - Info sul continente non disponibili 11
OC - Oceania 7
Totale 19.422
Nazione #
US - Stati Uniti d'America 12.805
IT - Italia 2.048
SG - Singapore 838
SE - Svezia 629
IN - India 603
CN - Cina 561
DE - Germania 354
FI - Finlandia 298
UA - Ucraina 145
GB - Regno Unito 118
RO - Romania 100
IE - Irlanda 97
CA - Canada 96
ID - Indonesia 82
NL - Olanda 68
TG - Togo 58
BG - Bulgaria 50
AR - Argentina 46
FR - Francia 45
JP - Giappone 41
RU - Federazione Russa 39
BE - Belgio 35
AT - Austria 18
GR - Grecia 18
CH - Svizzera 17
TR - Turchia 16
HK - Hong Kong 13
CL - Cile 11
CO - Colombia 11
EU - Europa 11
ZA - Sudafrica 11
KR - Corea 10
MX - Messico 10
PL - Polonia 10
BR - Brasile 8
NO - Norvegia 8
IR - Iran 7
PT - Portogallo 7
AU - Australia 6
ES - Italia 5
MK - Macedonia 5
DK - Danimarca 4
EG - Egitto 4
IL - Israele 4
LT - Lituania 4
PE - Perù 4
CZ - Repubblica Ceca 3
MY - Malesia 3
PH - Filippine 3
SC - Seychelles 3
VN - Vietnam 3
AL - Albania 2
AZ - Azerbaigian 2
EE - Estonia 2
HR - Croazia 2
IQ - Iraq 2
MA - Marocco 2
TW - Taiwan 2
VE - Venezuela 2
AE - Emirati Arabi Uniti 1
BD - Bangladesh 1
BO - Bolivia 1
BY - Bielorussia 1
HU - Ungheria 1
JO - Giordania 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LV - Lettonia 1
NZ - Nuova Zelanda 1
SA - Arabia Saudita 1
SI - Slovenia 1
TH - Thailandia 1
Totale 19.422
Città #
Fairfield 2.216
Ashburn 996
Woodbridge 969
Chandler 808
Seattle 806
Houston 782
Cambridge 759
Wilmington 712
Rome 707
Singapore 595
Dearborn 467
Ann Arbor 454
San Paolo di Civitate 376
Princeton 358
Plano 269
Lawrence 262
Santa Clara 258
Beijing 235
Boston 171
Millbury 157
San Diego 126
Fremont 123
New York 108
Helsinki 91
Des Moines 89
Dublin 87
Jakarta 79
Andover 78
Milan 73
Lomé 58
Norwalk 55
Boardman 54
Sofia 50
Bremen 49
Toronto 48
Falls Church 47
Horia 47
Ottawa 44
Federal 42
Hefei 42
Tokyo 37
Brussels 33
Kunming 32
Jacksonville 30
Phoenix 30
San Mateo 27
Nanjing 26
Mannheim 24
Falkenstein 22
Jinan 22
Los Angeles 21
Nürnberg 18
Guangzhou 17
Bühl 16
Istanbul 16
Amsterdam 15
London 15
Dallas 14
Groningen 13
Zhengzhou 13
Leawood 12
Monterotondo 12
Nanchang 12
Genoa 11
Indiana 11
Mumbai 11
Pune 11
Vienna 11
Deventer 10
Galdo 10
Redwood City 10
Shanghai 10
Southend 10
Turin 10
Auburn Hills 9
Latina 9
Verona 9
Hebei 8
Laurel 8
Medellín 8
Muizenberg 8
Napoli 8
Paris 8
Preganziol 8
St Louis 8
Bologna 7
Buffalo 7
Fort Worth 7
Hong Kong 7
L’Aquila 7
Mexico City 7
Moscow 7
Nettuno 7
Oslo 7
Palermo 7
Portici 7
Bari 6
Bern 6
Changsha 6
Chengdu 6
Totale 14.531
Nome #
Le moderne tecniche di Radioterapia 420
Neoadjuvant-intensified treatment for rectal cancer: Time to change? 182
Angiogenic factors as prognostic markers in neuroendocrine neoplasms 171
Psychological and functional effect of different primary treatments for prostate cancer: a comparative prospective analysis 142
Management of salivary gland malignant tumor: the Policlinico Umberto I, "Sapienza" University of Rome Head and Neck Unit clinical recommendations 139
Impact of induction chemotherapy in locally advanced HPV-negative oropharyngeal cancer. A propensity score-matched analysis 126
PARP inhibitors affect growth, survival and radiation susceptibility of human alveolar and embryonal rhabdomyosarcoma cell lines 126
Anorectal function and quality of life after chemoradiotherapy in patients with canal carcinoma 125
Alberta Capua 1946-2005 - Obituary 124
Follow-up program in head and neck cancer 120
Definitive intensity-modulated radiation therapy in elderly patients with locally advanced oropharyngeal cancer 120
Anaplastic thyroid carcinoma and foscarnet use in a multitarget treatment documented by 18F-FDG PET/CT: a case report 114
Dental cone beam computed tomography in children: clinical effectiveness and cancer risk due to radiation exposure 113
Fertility preservation in gynaecologic cancers 111
Crestal bone loss around dental implants placed in head and neck cancer patients treated with different radiotherapy techniques: a prospective cohort study 109
Advances in the management of HPV-related oropharyngeal cancer 108
Clinical target volume in biliary carcinoma: a systematic review of pathological studies 106
Unenhanced whole-body MRI versus PET-CT for the detection of prostate cancer metastases after primary treatment 104
Dose-dense weekly chemotherapy in advanced ovarian cancer: an updated meta-analysis of randomized controlled trials 104
An Analysis of the Global and Partial Voice Handicap Index in Patients with Early Glottic Carcinoma Treated with High Level of Irradiation 101
HDAC4 and HDAC6 sustain DNA double strand break repair and stem-like phenotype by promoting radioresistance in glioblastoma cells 100
The INCH trial - Induction chemotherapy in patients with bulky anal canal cancer: evaluation of the pilot phase 100
Risk-reducing salpingo-oophorectomy in BRCA1 and BRCA2 mutated patients: an evidence-based approach on what women should know 99
Successful role of adjuvant radiotherapy in a rare case of tracheal inflammatory myofibroblastic tumor: a case report 98
Radiotherapy in the treatment of stage III-IV hypopharyngeal carcinoma 98
Acute nonlymphocytic leukemia: onset after treatment for Hodgkin's disease. 96
The effect of post-mastectomy radiation therapy on breast implants: unveiling biomaterial alterations with potential implications on capsular contracture 96
Pharmacological targeting of the ephrin receptor kinase signalling by GLPG1790 in vitro and in vivo reverts oncophenotype, induces myogenic differentiation and radiosensitizes embryonal rhabdomyosarcoma cells 95
Immune check-point in cervical cancer 94
Basosquamous or basal cell carcinoma? The importance of the differential diagnosis 93
Clinical predictive factors of pathologic complete response in locally advanced rectal cancer 93
Weekly chemotherapy as first line treatment in frail head and neck cancer patients in the immunotherapy era 92
Tyrosine-kinases inhibitors in recurrent platinum-resistant ovarian cancer patients 91
Multimodality treatment of stage II thymic tumours 91
The effect of postmastectomy radiation therapy on breast implants. Material analysis on silicone and polyurethane prosthesis 90
c-Myc sustains transformed phenotype and promotes radioresistance of embryonal rhabdomyosarcoma cell lines 90
Tobacco, alcohol and family history of cancer as risk factors of oral squamous cell carcinoma: case-control retrospective study 90
Hormone replacement therapy after prophylactic risk-reducing salpingo-oophorectomy and breast cancer risk in BRCA1 and BRCA2 mutation carriers: a meta-analysis 89
Management of a rare case of squamous cell carcinoma of the tongue in a patient affected by progeria 89
Texture analysis as imaging biomarker of tumoral response to neoadjuvant chemoradiotherapy in rectal cancer patients studied with 3-T magnetic resonance 89
ANALYSIS OF THE RISK OF SOLID TUMOR FOLLOWING HODGKIN'S DISEASE 88
Effects of EGFR Tyrosine Kinase Inhibitor Erlotinib in Prostate Cancer Cells In Vitro 88
Weekly versus three weeks chemotherapy for advanced ovarian cancer: a meta-analysis 87
A new medical record proposal to the prognostic risk assessment for mronj in oncologic patients: “Sapienza head and neck unit” proposal 87
Adjuvant radiation therapy in stage I seminoma: 20 years of oncologic results 86
Corrigendum to Primary thyroid angiosarcoma: a systematic review 86
Sinonasal undifferentiated carcinoma in a patient previously treated for an intestinal-type adenocarcinoma: metachronous neoplasms or recurrence of a different tumor type? 86
Key role of MEK/ERK pathway in sustaining tumorigenicity and in vitro radioresistance of embryonal rhabdomyosarcoma stem-like cell population 85
Induction chemotherapy in nonlaryngeal human papilloma virus-negative high-risk head and neck cancer: a real-world experience 85
Induction chemotherapy followed by neoadjuvant chemoradiotherapy and surgery in locally advanced rectal cancer: preliminary results of a phase II study 84
Survival nomograms after curative neoadjuvant chemotherapy and radical surgery for stage IB2-IIIB cervical cancer 84
Antitumor effects of carnertinib in castration resistant prostate cancer models: A Comparative study with erlotinib. 83
Prostate cancer recurrence after radical prostatectomy: the role of 3-T diffusion imaging in multi-parametric magnetic resonance imaging 83
Can radiotherapy be combined with radiofrequency ablation in the management of symptomatic osteolytic skeletal metastasis? 83
Skin toxicity after radiotherapy: about a case 82
Head and neck cancer: metronomic chemotherapy 82
A feasibility study of percutaneous radiofrequency ablation followed by radiotherapy in the management of painful osteolytic bone metastases 82
Diffusion-weighted magnetic resonance imaging in locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy 81
Role of intraperitoneal chemotherapy in ovarian cancer in the platinum-taxane-based era: a meta-analysis 81
Unusual presentation of metastatic adenocarcinoma of the lung 81
Radiation therapy and serum salivary amylase in head and neck cancer 80
Dynamic contrast-enhanced magnetic resonance imaging in locally advanced rectal cancer: role of perfusion parameters in the assessment of response to treatment 80
A Feasibility Study of Percutaneous Radiofrequency Ablation with Radiotherapy in Painful Osteolytic Bone Metastases 79
Deep seated tumour treatments with electrons of high energy delivered at FLASH rates: the example of prostate cancer 79
Efficacy and toxicity of bevacizumab in recurrent ovarian disease: an update meta-analysis on phase III trials 78
Diffusion-weighted magnetic resonance imaging in painful bone metastases: using quantitative apparent diffusion coefficient as an indicator of effectiveness of single fraction versus multiple fraction radiotherapy 78
Radiotherapy controversies and prospective in head and neck cancer: a literature-based critical review 78
Buschke-Löwenstein tumor with squamous cell carcinoma treated with chemo-radiation therapy and local surgical excision: report of three cases. 78
Radiotherapy in indolent primary cutaneous B-cell lymphoma 77
Vitamin D protects endothelial cells from irradiation-induced senescence and apoptosis by modulating MAPK/SirT1 axis 77
Clinically relevant radioresistant rhabdomyosarcoma cell lines: functional, molecular and immune-related characterization 77
Erratum to "Strategies for Imaging Androgen Receptor Signaling Pathway in Prostate Cancer: Implications for Hormonal Manipulation and Radiation Treatment" 76
Defective DNA repair mechanisms in prostate cancer: impact of olaparib 76
Magnetic resonance tumor regression grade (MR-TRG) to assess pathological complete response following neoadjuvant radiochemotherapy in locally advanced rectal cancer 76
5-Azacitidine Restores and Amplifies the Bicalutamide Response on Preclinical Models of Androgen Receptor Expressing or Deficient Prostate Tumors 76
Impact of clinical complete response on treatment outcomes in patients with locally advanced HPV-negative oropharyngeal squamous cell carcinoma 76
Fractionated total body irradiation in allogeneic bone marrow transplantation in leukemia patients: analysis of prognostic factors and results in 136 patients. 75
5-azacitidine restores and amplifies the response to bicalutamide and radiotherapy on preclinical models of androgen receptor expressing or deficient prostate tumors 75
Nanotechnology in oral cavity carcinoma: recent trends and treatment opportunities 75
Disease control, survival, and toxicity outcome after intensified neoadjuvant chemoradiotherapy for locally advanced rectal cancer: a single-institution experience 74
Performance of diffusion-weighted imaging, perfusion imaging, and texture analysis in predicting tumoral response to neoadjuvant chemoradiotherapy in rectal cancer patients studied with 3T MR: initial experience 74
Diffusion-Weighted Magnetic Resonance Application in Response Prediction before, during, and after Neoadjuvant Radiochemotherapy in Primary Rectal Cancer Carcinoma 74
Pro-differentiating and radiosensitizing effects of inhibiting HDACs by PXD-101 (Belinostat) in in vitro and in vivo models of human rhabdomyosarcoma cell lines 74
MEK/ERK Inhibition by U0126 Radiosensitizes Rhabdomyosarcoma Cells In Vitro and In Vivo 73
Radiation target volume definition after induction chemotherapy in locally advanced rectal cancer 73
Metronomic chemotherapy in head and neck cancer 73
The addition of target therapy to neoadjuvant chemoradiotherapy in locally advanced rectal cancer: a review 73
The role of different adjuvant therapies in locally advanced gastric adenocarcinoma 73
Immune check-point in glioblastoma multiforme 73
Comparative study of testosterone and vitamin D analogue, elocalcitol, on insulin-controlled signal transduction pathway regulation in human skeletal muscle cells 73
BET inhibition therapy counteracts cancer cell survival, clonogenic potential and radioresistance mechanisms in rhabdomyosarcoma cells 73
New approaches in glioblastoma multiforme: the potential role of immune-check point inhibitors 72
Disruption of MEK/ERK/c-Myc signaling radiosensitizes prostate cancer cells in vitro and in vivo 72
Testosterone-mediated activation of androgenic signalling sustains in vitro the transformed and radioresistant phenotype of rhabdomyosarcoma cell lines 72
Radiation therapy in renal cell carcinoma 72
Phase 2 of coronavirus disease (COVID-19) and head and neck cancer: an action plan 72
Multiple bone metastases from glioblastoma multiforme without local brain relapse: A case report and review of the literature 72
Target volume delineation after induction chemotherapy in locally advanced head and neck cancer 71
Bullous pemphigoid induced by radiation therapy. 71
Pulsed-dose rate brachytherapy for the treatment of endometrial cancer 71
Totale 9.313
Categoria #
all - tutte 59.646
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 59.646


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20203.483 0 0 0 0 0 850 809 577 542 318 208 179
2020/20211.749 155 201 96 128 91 187 25 115 236 261 131 123
2021/20223.387 130 225 311 143 435 108 89 390 228 234 489 605
2022/20233.595 627 883 211 358 338 386 81 192 320 35 101 63
2023/20241.713 110 212 72 143 186 233 55 126 28 204 152 192
2024/20251.460 159 202 307 262 319 211 0 0 0 0 0 0
Totale 20.469